Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intranasal Insulin Effects on Appetite, Cognition and Reward
NCT03632681Completed
- Sponsor
- University of Birmingham
- Start
- Apr 2018
- Primary completion
- Apr 2019
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Randomised, double-blind trial of Generex Oral-lyn in obesity (2 arms), sponsored by University of Birmingham. Primary endpoint: fMRI brain response during inhibition to a food stimuli at 14 minutes. Started Apr 2018; status: completed.
02
Drugs
Generex Oral-lyn
03
Conditions
obesity
Beyond the preview
Go deeper on NCT03632681.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03632681.